Trimetazidine is a new metabolic antiischemic agent, which increases the tolerance of cardiomyocytes to ischemia. The aim of the study was to evaluate the effect of additional trimatazidine therapy in patients with ischemic cardiomyopathy (ICMP) in comparison with standard therapy of cardiac insufficiency. According to the results of the study, trimetazidine improves the clinical status, functional class of cardiac insufficiency, left ventricular ejection fraction, in ICMP patients. Trimetazidine increases physical exercise tolerance according to the results of six-minute walking test. Thus, the optimization of myocardial energetic metabolism may be a promising perspective in the treatment of coronary heart disease with systolic dysfunction.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Complete Left Bundle Branch Block With Pattern and Long-Term Outcomes.
Circ Arrhythm Electrophysiol
January 2025
Department of Cardiovascular Medicine (S.H., T.W., N.Z., J.W.).
The Relationship between Left Ventricular Diastolic Function Parameters and Coronary Artery Disease Severity.
Iran J Med Sci
December 2024
Cardiovascular Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Background: The relationship between diastolic function parameters and the severity of coronary artery disease (CAD) is controversial. This study aimed to determine the relationship between left ventricular diastolic function and the severity of CAD.
Methods: This cross-sectional study included 63 patients with Ischemic heart disease (IHD) or those suspected of having IHD, who underwent angiography.
Case Report: Left ventricular assist device implantation combined with cryoballoon ablation for ventricular tachycardia.
Front Surg
January 2025
Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
We report a case of a patient with dilated cardiomyopathy who experienced recurrent ventricular tachycardia (VT) and multiple defibrillations following CRT-D implantation. Due to worsening cardiac function, the patient required surgical implantation of a left ventricular assist device (LVAD) as a bridge to heart transplantation. During the procedure, we used the Ensite three-dimensional mapping system to perform activation and substrate mapping of the VT targets, followed by endocardial and epicardial cryoballoon ablation of clinical VT.
View Article and Find Full Text PDFOutcomes of Coronary Artery Bypass Grafting in Patients With Impaired Left Ventricular Function and the Role of Preoperative Myocardial Viability.
Cureus
December 2024
Cardiovascular Medicine, Hayatabad Medical Complex Peshawar, Peshawar, PAK.
Background Coronary artery bypass grafting (CABG) improves outcomes in patients with ischemic left ventricular (LV) dysfunction, but accurate patient selection remains critical. Late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) imaging aids in assessing myocardial viability, a key predictor of surgical outcomes. This study aimed to evaluate the impact of myocardial viability on postoperative outcomes in patients undergoing CABG.
View Article and Find Full Text PDFPrediction of reduced left ventricular ejection fraction using atrial fibrillation or flutter electrocardiograms: A machine-learning study.
Digit Health
January 2025
Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Objective: Although the evaluation of left ventricular ejection fraction (LVEF) in patients with atrial fibrillation (AF) or atrial flutter (AFL) is crucial for appropriate medical management, the prediction of reduced LVEF (<50%) with AF/AFL electrocardiograms (ECGs) lacks evidence. This study aimed to investigate deep-learning approaches to predict reduced LVEF (<50%) in patients with AF/AFL ECGs and easily obtainable clinical information.
Methods: Patients with 12-lead ECGs of AF/AFL and echocardiography were divided into those with LVEF <50% and ≥50%.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!